“…1 The citation for the advice provided does not make any reference to leflunomide. 7 Low-to-moderate doses of CS (dose equivalent to prednisone ≤10 mg/day), leflunomide, sulfasalazine and MTX (≤0.4 mg/kg per week) and AZA (≤3 mg/kg per day) are not a contraindication. 7 This error has the potential to result in a serious adverse event and needs urgent correction.…”
Section: No Live Vaccines For People Being Treated With Leflunomidementioning
confidence: 99%
“…While disseminated HZ post-ZVL can occur, it is most often described in those with haematologic malignancy. 6,7 A US study of 14 554 people who had an…”
“…1 The citation for the advice provided does not make any reference to leflunomide. 7 Low-to-moderate doses of CS (dose equivalent to prednisone ≤10 mg/day), leflunomide, sulfasalazine and MTX (≤0.4 mg/kg per week) and AZA (≤3 mg/kg per day) are not a contraindication. 7 This error has the potential to result in a serious adverse event and needs urgent correction.…”
Section: No Live Vaccines For People Being Treated With Leflunomidementioning
confidence: 99%
“…While disseminated HZ post-ZVL can occur, it is most often described in those with haematologic malignancy. 6,7 A US study of 14 554 people who had an…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.